Premium
ImmunityBio Inc (IBRX)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-03-31 | California Capital Equity, LLCSociété | 4,61M | 25,00M | Derivative Exercise and Retained Stock | 5,43 | 259,00M | 1,81% |
| 2026-02-24 | Dr. Barry J. SimonChief Corporate Affairs Officer & Director | -75,00k | 900,79k | Automatic Disposition | 12,01 | 2,85M | -2,56% |
| 2026-02-23 | Ms. Christobel E. SeleckyIndependent Director | -25,00k | 175,50k | Derivative Exercise and Sale | 2,98 - 10,00 | 0,00 | - |
| 2026-02-22 | Ms. Regan J. LauerCAO | 2,39k | 0,00 | Derivative Exercise and Retained Stock | - | 115,88k | 2,11% |
| 2026-02-22 | Ms. Regan J. LauerCAO | -1,67k | 14,56k | Derivative Exercise and Sale | 8,70 | 115,88k | - |
| 2026-02-22 | Mr. Richard Gerald AdcockPresident, CEO & Director | 74,88k | 0,00 | Derivative Exercise and Retained Stock | - | 560,34k | 15,42% |
| 2026-02-22 | Mr. Richard Gerald AdcockPresident, CEO & Director | -77,56k | 674,77k | Derivative Exercise and Sale | 8,70 | 560,34k | - |
| 2026-02-22 | Mr. David C. SachsCFO | 19,97k | 0,00 | Derivative Exercise and Retained Stock | - | 300,14k | 7,13% |
| 2026-02-22 | Mr. David C. SachsCFO | -20,68k | 179,93k | Derivative Exercise and Sale | 8,70 | 300,14k | - |
| 2026-02-22 | Dr. Patrick Soon-ShiongFounder, Executive Chairman and Global Chief Scientific & Medical Officer | 56,16k | 0,00 | Derivative Exercise and Retained Stock | - | 291,46M | 0,02% |
| 2026-02-22 | Dr. Patrick Soon-ShiongFounder, Executive Chairman and Global Chief Scientific & Medical Officer | -58,17k | 506,08k | Derivative Exercise and Sale | 8,70 | 291,46M | - |
| 2026-02-22 | Dr. Barry J. SimonChief Corporate Affairs Officer & Director | -15,24k | 146,89k | Derivative Exercise and Sale | 8,70 - 10,25 | 2,93M | - |
| 2026-02-20 | Dr. Barry J. SimonChief Corporate Affairs Officer & Director | -165,78k | 1,69M | Automatic Disposition | 9,25 - 10,25 | 2,93M | -5,36% |
| 2026-02-10 | Dr. Patrick Soon-ShiongFounder, Executive Chairman and Global Chief Scientific & Medical Officer | 155,56k | 0,00 | Derivative Exercise and Retained Stock | - | 291,41M | 0,05% |
| 2026-02-10 | Dr. Patrick Soon-ShiongFounder, Executive Chairman and Global Chief Scientific & Medical Officer | -118,56k | 821,62k | Derivative Exercise and Sale | 6,93 | 291,41M | - |
| 2026-02-10 | Mr. David C. SachsCFO | 39,59k | 0,00 | Derivative Exercise and Retained Stock | - | 280,18k | 16,46% |
| 2026-02-10 | Mr. David C. SachsCFO | -42,64k | 295,52k | Derivative Exercise and Sale | 6,93 | 280,18k | - |
| 2026-02-10 | Ms. Regan J. LauerCAO | 3,23k | 0,00 | Derivative Exercise and Retained Stock | - | 113,48k | 2,92% |
| 2026-02-10 | Ms. Regan J. LauerCAO | -2,26k | 15,64k | Derivative Exercise and Sale | 6,93 | 113,48k | - |
| 2026-02-10 | Mr. Richard Gerald AdcockPresident, CEO & Director | 134,07k | 0,00 | Derivative Exercise and Retained Stock | - | 485,47k | 38,16% |
| 2026-02-10 | Mr. Richard Gerald AdcockPresident, CEO & Director | -140,05k | 970,53k | Derivative Exercise and Sale | 6,93 | 485,47k | - |
| 2026-01-20 | Dr. Barry J. SimonChief Corporate Affairs Officer & Director | -151,97k | 1,09M | Automatic Disposition | 6,54 - 7,88 | 3,09M | -4,69% |
| 2026-01-16 | Ms. Christobel E. SeleckyIndependent Director | -75,00k | 214,15k | Derivative Exercise and Sale | 2,98 - 7,51 | 0,00 | - |
| 2025-12-31 | Mr. David C. SachsCFO | 14,96k | 0,00 | Derivative Exercise and Retained Stock | - | 240,58k | 6,63% |
| 2025-12-31 | Mr. David C. SachsCFO | -15,44k | 30,56k | Derivative Exercise and Sale | 1,98 | 240,58k | - |
| 2025-12-31 | Mr. Richard Gerald AdcockPresident, CEO & Director | 16,97k | 0,00 | Derivative Exercise and Retained Stock | - | 351,39k | 5,08% |
| 2025-12-31 | Mr. Richard Gerald AdcockPresident, CEO & Director | -17,51k | 34,67k | Derivative Exercise and Sale | 1,98 | 351,39k | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
